Harris Hall, an analyst at Wedbush Morgan in Los Angeles, said there was now 'a little bit of froth in the stock'. He rates the stock as a hold, arguing that the surge in Uggs disguises the fact that two thirds of Deckers' business is in sales of its Teva sandals. 'Teva has great growth opportunity,' he said.